PARVA expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.091400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.802400E-01
Normal-vs-Stage2
6.349200E-01
Normal-vs-Stage3
9.996800E-01
Normal-vs-Stage4
3.643600E-01
Stage1-vs-Stage2
3.675000E-01
Stage1-vs-Stage3
8.341000E-01
Stage1-vs-Stage4
1.160810E-01
Stage2-vs-Stage3
5.821200E-01
Stage2-vs-Stage4
2.080000E-01
Stage3-vs-Stage4
2.365000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.408800E-01
Normal-vs-AfricanAmerican
6.328200E-01
Normal-vs-Asian
7.999200E-01
Caucasian-vs-AfricanAmerican
6.737400E-01
Caucasian-vs-Asian
8.978200E-01
AfricanAmerican-vs-Asian
8.395200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.640400E-01
Normal-vs-Female
6.383600E-01
Male-vs-Female
6.660000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.155600E-01
Normal-vs-Age(41-60Yrs)
4.467400E-01
Normal-vs-Age(61-80Yrs)
8.018400E-01
Normal-vs-Age(81-100Yrs)
9.410600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.339000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.614800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.393000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.424170E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.989390E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.182600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.853200E-01
Normal-vs-Daily Drinker
6.259200E-01
Normal-vs-Weekly Drinker
5.285200E-01
Normal-vs-Occasional Drinker
6.751800E-01
Normal-vs-Social Drinker
4.905000E-01
Non Drinker-vs-Daily Drinker
2.689600E-01
Non Drinker-vs-Weekly Drinker
1.672240E-01
Non Drinker-vs-Occasional Drinker
2.614400E-01
Non Drinker-vs-Social Drinker
1.232390E-01
Daily Drinker-vs-Weekly Drinker
6.106000E-02
Daily Drinker-vs-Occasional Drinker
7.148400E-02
Daily Drinker-vs-Social Drinker
4.655600E-02
Weekly Drinker-vs-Occasional Drinker
5.480000E-01
Weekly Drinker-vs-Social Drinker
8.240000E-01
Occasional Drinker-vs-Social Drinker
4.087000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.025600E-01
Normal-vs-Grade 2
1.991190E-01
Normal-vs-Grade 3
2.897400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.460700E-03
Grade 1-vs-Grade 3
6.887600E-02
Grade 1-vs-Grade 4
7.025600E-01
Grade 2-vs-Grade 3
4.843200E-01
Grade 2-vs-Grade 4
1.991190E-01
Grade 3-vs-Grade 4
2.897400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.424200E-01
Normal-vs-NonDiabetic
7.797600E-01
Diabetic-vs-NonDiabetic
7.432400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.435200E-01
Normal-vs-NoPancreatitis
7.837200E-01
Pancreatitis-vs-NoPancreatitis
2.115600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.537200E-01
Normal-vs-N1
6.201200E-01
N0-vs-N1
2.727400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.272000E-01
Normal-vs-TP53-NonMutant
9.410600E-01
TP53-Mutant-vs-TP53-NonMutant
1.518000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
